Its mission is to provide the highest level of quality and cutting-edge services to facilitate and advance the definition of the best therapy for the patient and close the cycle from basic research to the completion of the clinical application.

In 2002, the Oncology Plan of Catalonia promoted the creation of a network of tumor banks in Catalonia that would serve to provide sufficient samples for cancer research and to obtain useful results in the diagnosis and treatment of these patients. One of the most important resources for the development of these studies are tumor tissues and other samples (serum, cell cultures) from patients affected by this disease as well as healthy control tissues. From these types of samples it is possible to obtain DNA, RNA, proteins and other products useful for research.

Martinez Valenzuela L, Draibe J, Quero M, et al.

Llorens F, Hermann P, Villar-Piqué A, et al.

Esteve P, Rueda-Carrasco J, Inés Mateo M, et al.

Mur P, Farcia-Mulero MS, Valle L, et al.

Pérez R, Tejedor J, Santamarina-Ojeda P, et al.

European infrastructure for translational medicine. We pool resources and services for research communities to translate scientific discoveries into benefits for patients.

Mission: Promotion of excellence in cancer research in Spain, as well as the incorporation of new findings into clinical practice.

Mission: Lead the research effort of excellence in diabetes and associated metabolic diseases, as well as accelerate the translation of scientific results into clinical practice to improve the health of the population and people with diabetes and metabolic diseases.

Mission: Provide answers and solutions to treat mental illness and thus improve the quality of life of citizens

Mission: Assist in advancing the understanding of the mechanisms that contribute to the development of obesity to reduce its incidence and prevalence, as well as complications, in addition to nutrition-related diseases. Through its leadership in translational biomedical research, it integrates basic, clinical, epidemiological and public health research, as well as medical care and education in the public sphere of obesity and nutrition, becoming for all this in a research center of reference with a competitive potential of internationalization and to provide services of consultancy in R&D and companies so much pharmaceutical as of the feeding, as well as the sanitary authorities of the country.

Mission: to create a stable network research structure in this area to allow the promotion of research and technical activity in a horizontal field of human health and, thus, to establish the essential bases for the development of the Public Health policies of the different responsible administrations. of the National Health System. This requires the coordination, collaboration and strategic and economic management of research groups distributed throughout the geography.

Mission: Our mission is to be a center where collaboration and cooperation between biomedical and clinical research groups prevail and are favored, with special emphasis on the aspects of genetic, molecular, biochemical and cell research. of rare, genetic or acquired diseases. The aim is to improve our knowledge of the epidemiology, causes and production mechanisms of rare diseases. This research is the basis for providing new tools for the diagnosis and therapy of rare diseases, encouraging translational or translational research between the scientific environment of the laboratory and the clinical environment of health centers.

Mission: CIBEREHD is a consortium with its own legal personality, without physical contiguity, which aims to promote and collaborate in scientific research, development of knowledge and its transfer to society, in the area of ​​liver and digestive diseases.

Carry out research of excellence aimed at transfer to industry and clinical translation through the development of the scientific areas of bioengineering, biomaterials and nanomedicine

SCReN: Support for multicenter clinical trials Achieve an advanced level of technical competence in the processes related to the development and management of clinical research, ensure compliance with legal requirements and the competence of researchers participating in platform studies on methodological aspects and PCBs. others.

Contribute to the design and development of projects in the field of biotechnology and biomedicine, establish new concepts in biology, identify new diagnostic and therapeutic targets, promote the development of new biopharmaceuticals and dissect the mechanism of action. of drugs and their selective effects on specific individuals.

It consists of three technology platforms - ProteoRed (proteomics) CeGen (genomics), INB (bioinformatics) - and two biobanks: BNADN (DNA bank) and BNLC (cell line bank). It encompasses different complementary disciplines that allow the management and management of complex research in biomedicine. The most advanced technology is offered to the scientific community in a comprehensive way, always with the support of the best scientists in their respective specialties, which facilitate the design of the experiment, the analytical process and the processing and interpretation of data. interpretation of the data.

BioCores is a directory of basic facilities, technology platforms and scientific services currently in Spain. BioCores offers a tool to find a wide range of cutting-edge, state-of-the-art scientific services, techniques and equipment, to support both biomedical and life sciences research and the scientific community.

REGIC is the first association of clinical research management organizations created in Spain at the request of professionals, to share experiences and create a space for interaction and training in the management of healthcare R & D & I.

The BCTP has as its great challenge to advance the arrival of innovative treatments to patients in Catalonia. BCTP needs to improve the coordination, integration, quality, inclusiveness and speed of clinical research. This will be thanks to the optimization and homogenization of the clinical research processes of its members, as well as the human and technological potential of the centers. In addition, the BCTP will function as a dissemination platform to attract new studies from outside Catalonia.

The Center for Genomic Regulation (CRG) has partnered with several leading hospital research institutes in Catalonia to create a new state-of-the-art infrastructure to study and analyze proteins. It is the first such collaboration between biomedical research institutes and hospitals. The state-of-the-art equipment acquired will help meet the growing demand for protein analysis from Catalan research and innovation institutions.

Bioinformatics Barcelona (BIB) is an association for the provision of education and training, the promotion of advanced research, the transfer of knowledge and technology, the stimulation of competitiveness and innovation in the industrial sector, and the provision of 'greater visibility as an international entity. BIB was born to cover the need to generate synergies between biology and computer science, for a stronger union between these areas and for the development of high quality education and training programs in the creation of bioinformatics talent.